Inmaculada Rapado

2.8k total citations
30 papers, 370 citations indexed

About

Inmaculada Rapado is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Inmaculada Rapado has authored 30 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 12 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Inmaculada Rapado's work include Acute Myeloid Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Inmaculada Rapado is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Inmaculada Rapado collaborates with scholars based in Spain, United States and Germany. Inmaculada Rapado's co-authors include Joaquín Martínez‐López, Miguel Gallardo, Rosa Ayala, Florinda Gilsanz, José‐Ángel Hernández‐Rivas, Jan Parker‐Thornburg, Carlos E. Bueso‐Ramos, Mark J. McArthur, Alfonso Quintás‐Cardama and Steven M. Kornblau and has published in prestigious journals such as Blood, Cancer Cell and Scientific Reports.

In The Last Decade

Inmaculada Rapado

27 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inmaculada Rapado Spain	10	238	163	112	64	64	30	370
Niklas Landberg Sweden	10	114 0.5×	149 0.9×	62 0.6×	58 0.9×	69 1.1×	17	289
Fiorella Schischlik Austria	9	215 0.9×	70 0.4×	78 0.7×	37 0.6×	68 1.1×	19	314
L C Chan Hong Kong	7	221 0.9×	194 1.2×	101 0.9×	43 0.7×	32 0.5×	10	399
Fiona Watkins United Kingdom	6	180 0.8×	246 1.5×	117 1.0×	31 0.5×	38 0.6×	8	379
Nicole Duclos United States	8	326 1.4×	323 2.0×	161 1.4×	25 0.4×	84 1.3×	9	551
Yebin Ahn United States	3	389 1.6×	251 1.5×	64 0.6×	59 0.9×	102 1.6×	4	601
Nerea Marcotegui Spain	10	283 1.2×	160 1.0×	50 0.4×	75 1.2×	45 0.7×	12	374
Gabriella Ciceri Italy	7	206 0.9×	142 0.9×	58 0.5×	80 1.3×	78 1.2×	9	290
Kathleen Hueneman United States	9	207 0.9×	207 1.3×	62 0.6×	62 1.0×	48 0.8×	24	392
Carola Reindl Germany	7	164 0.7×	275 1.7×	160 1.4×	15 0.2×	38 0.6×	8	359

Countries citing papers authored by Inmaculada Rapado

Since Specialization

Citations

This map shows the geographic impact of Inmaculada Rapado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Rapado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Rapado more than expected).

Fields of papers citing papers by Inmaculada Rapado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Rapado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Rapado. The network helps show where Inmaculada Rapado may publish in the future.

Co-authorship network of co-authors of Inmaculada Rapado

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Rapado. A scholar is included among the top collaborators of Inmaculada Rapado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Rapado. Inmaculada Rapado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ubieto, Ana Jiménez, Margarita Rodríguez, Esther Parra-Mora, et al.. (2024). Clinical Utility of Ctdna Detection By NGS for Diagnosis of CNS Lymphoma. Blood. 144(Supplement 1). 6227–6227. 1 indexed citations

Martı́n, Alejandro, Margarita Rodríguez, Alicia Giménez Pérez, et al.. (2024). Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges. Frontiers in Immunology. 15. 1252258–1252258. 4 indexed citations

Ayala, Rosa, et al.. (2023). Impact of IPSS-M implementation in real-life clinical practice. Frontiers in Oncology. 13. 1199023–1199023. 3 indexed citations

Leivas, Alejandra, Ruth M. Risueño, Manuel Pérez‐Martínez, et al.. (2021). Natural killer cells efficiently target multiple myeloma clonogenic tumor cells. Cancer Immunology Immunotherapy. 70(10). 2911–2924. 9 indexed citations

Bodega‐Mayor, Irene, Francisca Molina‐Jiménez, Martín González‐Andrade, et al.. (2020). TYK2 Variants in B-Acute Lymphoblastic Leukaemia. Genes. 11(12). 1434–1434. 7 indexed citations

Rapado, Inmaculada, María Luz Morales, Gonzalo Carreño‐Tarragona, et al.. (2020). Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse. Haematologica. 106(9). 2325–2333. 19 indexed citations

Izquierdo, Antonia Rodríguez, Jaime Carrillo, Ricardo Sánchez, et al.. (2020). Minimal Residual Disease Monitoring from Liquid Biopsy By Next Generation Sequencing in Follicular Lymphoma Patients. Blood. 136(Supplement 1). 31–33. 4 indexed citations

Martínez‐Cuadrón, David, Eva Barragán, Pilar Martínez‐Sánchez, et al.. (2020). Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity. British Journal of Haematology. 189(4). 672–683. 7 indexed citations

Sánchez, Ricardo, Jaime Carrillo, Chongwu Wang, et al.. (2020). Detection of Emerging Resistant Clones in Philadelphia-Positive Leukemia Patients Exposed to Tyrosine Kinase Inhibitors. Correlation of cDNA and Gdna Approaches. Blood. 136(Supplement 1). 6–8.

10.

Morales, María Luz, Alejandra Leivas, Inmaculada Rapado, et al.. (2019). MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia. Scientific Reports. 9(1). 18630–18630. 24 indexed citations

11.

Ayala, Rosa, Pilar Hernández-Campo, María Luz Morales, et al.. (2018). Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms. Haematologica. 104(5). 937–946. 7 indexed citations

12.

Pernas, Sònia, Aleix Prat, Octavio Burgués, et al.. (2017). AGATA molecular screening program: Implementing precision medicine in patients with advanced breast cancer in Spain. Annals of Oncology. 28. v104–v105. 1 indexed citations

13.

Cedena, María‐Teresa, Inmaculada Rapado, Alejandro Santos‐Lozano, et al.. (2017). Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes. Oncotarget. 8(63). 106948–106961. 29 indexed citations

14.

Gallardo, Miguel, Hun Ju Lee, Xiaorui Zhang, et al.. (2015). hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies. Cancer Cell. 28(4). 486–499. 110 indexed citations

15.

Gallardo, Miguel, Santiago Barrio, Inmaculada Rapado, et al.. (2011). Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia. Annals of Hematology. 90(8). 939–946. 6 indexed citations

16.

Barrio, Santiago, Miguel Gallardo, Ana Jiménez Ubieto, et al.. (2011). Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation. Journal of Clinical Pathology. 64(11). 1010–1013. 20 indexed citations

17.

Rivero, Ana, Inmaculada Rapado, José Francisco Tomás, et al.. (2010). Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma. Leukemia Research. 35(4). 431–437. 4 indexed citations

18.

Martínez‐López, Joaquín, Ana Rivero, Inmaculada Rapado, et al.. (2009). Influence ofMBL-2mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide. Leukemia & lymphoma. 50(8). 1283–1289. 4 indexed citations

19.

Rapado, Inmaculada, Rosa Ayala, José‐Ángel Hernández‐Rivas, et al.. (2009). High Resolution Melting Analysis for JAK2 Exon 14 and Exon 12 Mutations. Journal of Molecular Diagnostics. 11(2). 155–161. 41 indexed citations

20.

Rapado, Inmaculada, Rosa Ayala, José‐Ángel Hernández‐Rivas, et al.. (2008). Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases. Annals of Hematology. 87(9). 741–749. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact